Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility Assurance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. ACN
5. IBM
6. DPZ
7. NVDA
8. PRIM
9. META
10. SPY

Go back to Endo Pharmaceuticals Inc. Issues Voluntary Nationwide Recall for One Lot of Edex® (alprostadil for injection) 10 mcg 2 Pack Carton Due to Potential Lack of Sterility Assurance

Guggenheim Reiterates Buy on Endo Int'l (ENDP) Following 4Q Beat

February 28, 2017 11:45 AM EST

Guggenheim reiterated a Buy rating and $35.00 price target on Endo International plc (NASDAQ: ENDP) following the company's 4Q earnings report. ENDP reported 4Q16 adjusted EPS of $1.77, $0.14 higher than consensus. Management gave '17 EPS guidance of $3.45-$3.75, midpoint $3.60 (consensus was $4.27).

Analyst Louise Chen... More